These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24367141)

  • 1. Charged particle radiotherapy at the Hyogo Ion Beam Medical Center: Characteristics, technology and clinical results.
    Abe M
    Proc Jpn Acad Ser B Phys Biol Sci; 2007 Sep; 83(6):151-63. PubMed ID: 24367141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors.
    Gamez ME; Patel SH; McGee LA; Sio TT; McDonald M; Phan J; Ma DJ; Foote RL; Rwigema JM
    Int J Part Ther; 2021; 8(1):131-154. PubMed ID: 34285942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status and future of particle radiotherapy at the Hyogo Ion Beam Medical Center].
    Murakami M; Hishikawa Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1791-4. PubMed ID: 19920379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion.
    Morimoto K; Demizu Y; Hashimoto N; Mima M; Terashima K; Fujii O; Otsuki N; Murakami M; Fuwa N; Nibu K
    Jpn J Clin Oncol; 2014 May; 44(5):428-34. PubMed ID: 24620027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation and perspective of charged particle therapy].
    Tsujii H
    Nihon Rinsho; 1997 Jun; 55(6):1588-95. PubMed ID: 9200952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Report on proton therapy according to good clinical practice at Hyogo Ion Beam Medical Center].
    Murakami M; Kagawa K; Hishikawa Y; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Feb; 62(2):79-85. PubMed ID: 11905036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Particle beam radiotherapy].
    Saitoh J; Nakano T
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2546-9. PubMed ID: 25596047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy with charged particles.
    Schulz-Ertner D; Jäkel O; Schlegel W
    Semin Radiat Oncol; 2006 Oct; 16(4):249-59. PubMed ID: 17010908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors.
    Miyawaki D; Murakami M; Demizu Y; Sasaki R; Niwa Y; Terashima K; Nishimura H; Hishikawa Y; Sugimura K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):378-84. PubMed ID: 19735866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of particle radiotherapy in the treatment of skull base tumors.
    Iannalfi A; Riva G; Ciccone L; Orlandi E
    Front Oncol; 2023; 13():1161752. PubMed ID: 37350949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of clinical results of charged-particle therapy for esophageal cancer.
    Ono T
    Esophagus; 2021 Jan; 18(1):33-40. PubMed ID: 32654019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heavy charged particle radiotherapy--proton beam].
    Ogino T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric robustness against setup errors in charged particle radiotherapy of skull base tumors.
    Ammazzalorso F; Jelen U; Engenhart-Cabillic R; Schlegel W
    Radiat Oncol; 2014 Dec; 9():279. PubMed ID: 25477197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
    Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients.
    Combs SE; Ellerbrock M; Haberer T; Habermehl D; Hoess A; Jäkel O; Jensen A; Klemm S; Münter M; Naumann J; Nikoghosyan A; Oertel S; Parodi K; Rieken S; Debus J
    Acta Oncol; 2010 Oct; 49(7):1132-40. PubMed ID: 20831505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle therapy for prostate cancer: The past, present and future.
    Ishikawa H; Tsuji H; Murayama S; Sugimoto M; Shinohara N; Maruyama S; Murakami M; Shirato H; Sakurai H
    Int J Urol; 2019 Oct; 26(10):971-979. PubMed ID: 31284326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present status of carbon ion radiotherapy for malignant tumors].
    Sugahara S; Kamada T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
    Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
    Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base.
    Combs SE; Kessel K; Habermehl D; Haberer T; Jäkel O; Debus J
    Acta Oncol; 2013 Oct; 52(7):1504-9. PubMed ID: 23962241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.